PURE Bioscience, Inc.
PURE
Rank in Stocks
#29261
PURE Bioscience, Inc. develops and commercializes antimicrobial products that... PURE Bioscience, Inc. develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The companyβs technology platform contains silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds. It offers SDC-based disinfecting and sanitizing products, including PURE Hard Surface, a ready-to-use hard surface disinfectant and food contact surface sanitizer and disinfectant; PURE Control, eliminates pathogens in produce, such as salmonella, e. coli, and listeria; PURE Multi-Purpose Hi-Foam Floor Cleaner Concentrate, a cleaning product for stainless steel, floors, walls, and painted areas; PURE Multi-Purpose Floor Cleaner, for sanitation in food processing plants, commercial kitchens, healthcare facilities, schools, and hospitality settings; and SILVERION, a SDC-based antimicrobial formulation for use as a raw material ingredient in the manufacturing of personal care products. The company serves food processing, food service and hospitality, healthcare, facility care, transportation, and personal care industries. It sells its products through end-use customers and third-party distributors. The company was incorporated in 1992 and is based in El Cajon, California.
Share Price
$0.065
Last synced: 2026-11-09
Market Cap
$8.45M
Change (1 day)
8.33%
Change (1 year)
23.79%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade PURE Bioscience, Inc. (PURE)
Category
Basic Materials
Operating Margin for PURE Bioscience, Inc. (PURE)
Operating Margin as of November 2026 TTM: -89.86%
According to PURE Bioscience, Inc.'s latest financial reports, its current operating margin (TTM) is -89.86%. At the end of 2025 the company had an operating margin of -103.18%.
Operating Margin history for PURE Bioscience, Inc. from 2000 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -89.86% | -12.91% |
| 2025 | -103.18% | -35.31% |
| 2024 | -159.50% | -24.07% |
| 2023 | -210.07% | 13.65% |
| 2022 | -184.84% | 214.09% |
| 2021 | -58.85% | -45,369.23% |
| 2020 | 0.13% | -100.04% |
| 2019 | -292.77% | -26.25% |
| 2018 | -396.96% | 20.98% |
| 2017 | -328.13% | -1,812.58% |
| 2016 | 19.16% | -101.83% |
| 2015 | -1,048.01% | -36.99% |
| 2014 | -1,663.27% | 100.93% |
| 2013 | -827.80% | -23.22% |
| 2012 | -1,078.08% | -40.19% |
| 2011 | -1,802.51% | 279.68% |
| 2010 | -474.75% | -51.54% |
| 2009 | -979.65% | 118.13% |
| 2008 | -449.11% | -68.79% |
| 2007 | -1,439.05% | -22.31% |
| 2006 | -1,852.32% | -4.16% |
| 2005 | -1,932.65% | 93.90% |
| 2004 | -996.75% | 704.15% |
| 2003 | -123.95% | 79.02% |
| 2002 | -69.24% | -8.23% |
| 2001 | -75.45% | -32.57% |
| 2000 | -111.90% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 6.22% | -100.07% |
TW
|
|
| 25.36% | -100.28% |
JP
|
|
| 4.23% | -100.05% |
DE
|
|
| 7.07% | -100.08% |
SA
|
|
| 2.91% | -100.03% |
CN
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about PURE Bioscience, Inc.'s operating margin
What is PURE Bioscience, Inc.'s operating margin?
PURE Bioscience, Inc.'s operating margin is -89.86%, as of Nov 2026.
What was PURE Bioscience, Inc.'s operating margin in 2025?
In 2025, PURE Bioscience, Inc.'s operating margin was -103.18%, compared with -159.50% in 2024.
How has PURE Bioscience, Inc.'s operating margin changed since 2020?
From 2020 to 2025, PURE Bioscience, Inc.'s operating margin was highest in 2020 (0.13%) and lowest in 2023 (-210.07%).
How does PURE Bioscience, Inc.'s operating margin compare with similar companies?
PURE Bioscience, Inc.'s operating margin (-89.86%) is lower than that of all 5 similar companies listed above. The highest among them is Shin-Etsu Chemical Co., Ltd., with 25.36%.